As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Thermo Fisher Scientific: JPMorgan Chase & Co., Susquehanna International Group LLP, Jane Street Group LLC, Squarepoint Ops LLC, Cubist Systematic Strategies LLC, Lido Advisors LLC, Two Sigma Securities LLC, Freestone Capital Holdings LLC, Oribel Capital Management LP, Eisler Capital UK Ltd., Group One Trading L.P., BNP Paribas Arbitrage SNC, PEAK6 Investments LLC, Bank of America Corp DE, UBS Group AG, HighTower Advisors LLC, Citigroup Inc., Garda Capital Partners LP, Twin Tree Management LP, Capstone Investment Advisors LLC, Gladius Capital Management LP, Wolverine Asset Management LLC, SG Americas Securities LLC, Simplex Trading LLC, IMC Chicago LLC, SpiderRock Advisors LLC, and Focused Wealth Management Inc. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.